Alcon Research

This study tested a new eye drop called Reformulated PG324 to see how well it lowers eye pressure in people with open-angle glaucoma or high eye pressure. About 489 adults took part. The goal was to measure the drop's safety and effectiveness in controlling eye pressure, which is…

This study tested whether a new eye drop called AR-15512 can improve the health of the eye surface in people with dry eye disease. 80 participants received either the new drops or artificial tears. The main goal was to see if the drops increased the number of goblet cells, which …

This study looked at the long-term safety and performance of AcrySof PanOptix trifocal lenses in 211 people who had them implanted in both eyes 3 to 5 years earlier. Researchers checked vision and recorded any eye problems or device issues. The goal was to make sure these lenses …

This phase 2 trial tested two new eye drop formulas, AR-17043 and PG043, in 426 people with open-angle glaucoma or ocular hypertension. The goal was to see if they safely lower eye pressure better than existing drops. Participants received different doses of the study drops or st…

This completed study tested how well delefilcon A contact lenses with different diameters and base curves fit the eyes of 257 people with nearsightedness. Researchers checked lens movement and centration right after insertion and again after 6 hours. The goal was to find which le…

This study tested a newer trifocal lens implant (Clareon PanOptix Pro) against an older one (Clareon PanOptix) in 71 adults having cataract surgery in both eyes. Each person got one of each lens, so their eyes could be compared directly. The goal was to see if the newer lens prov…

This study tested the safety of AR-15512 eye drops in 55 people with dry eye disease. Participants received the drops at different temperatures and with eyes open or closed to see if these factors affect side effects. The goal was to measure how many people had eye-related side e…

This study tested a new eye drop formula in 188 adults with mild to moderate dry eye disease. Participants used the drops for 30 days and reported how much their symptoms bothered them. The goal was to see if the drops safely improve comfort.

This completed Phase 3b trial tested AR-15512 eye drops in 81 adults with dry eye disease. The goal was to see if a single dose could quickly increase tear production, measured by tear meniscus height. The study was open-label, meaning everyone knew they were getting the active d…

This completed Phase 3 trial tested whether FID 123320 eye drops can safely reduce eye redness caused by minor irritations. The study involved 283 children and adults who used either the active drops or a placebo. Researchers measured redness at several time points, from 1 minute…

This study tested new multifocal contact lenses designed for people with both presbyopia (age-related blurry near vision) and astigmatism (blurry vision due to an irregularly shaped cornea). 95 habitual contact lens wearers wore the lenses for 30 days, and researchers measured ho…

This study tested two different trifocal lens implants used during cataract surgery to see which one gives better vision. 87 people who needed cataract surgery in both eyes received one type of lens in each eye. The main goal was to measure how clearly they could see letters on a…

This study tested whether a special eye drop (apraclonidine) can safely reduce eye redness caused by minor irritations. 159 adults who often use redness-relief drops took part. Researchers measured redness before and after using the drops, checking at 15 minutes and 10 hours late…

This study tested two different multifocal contact lenses in 106 people with presbyopia, an age-related condition that makes it hard to see up close. Participants wore each lens for a week to see how well they could see at different distances. The goal was to compare the performa…

This study looked at how well the Clareon Vivity and Vivity Toric intraocular lenses work in people who already had cataract surgery. Researchers measured vision at different distances in 155 participants. The goal was to confirm the lenses perform as expected and support their u…